2.11 USD
↘ 0.11 (4.74%)AT CLOSE (03:59 PM EDT)
BioLineRX Ltd
BLRXNASDAQ • USD
2.08
↘ 0.03 (1.66%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.08
↘ 0.03 (1.66%)
Market: CLOSED
BioLineRX Ltd (BLRX) is currently trading at $2.04. Technical indicators currently signal "Sell". Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 21, 2026.
Open?$2.19
High?$2.19
Low?$1.96
Prev. Close?$2.21
Volume?1.9K
Avg. Volume?N/A
VWAP?$2.14
Bid / Ask
Bid?$1.94 × 300
Ask?$2.26 × 200
Spread?$0.32
Midpoint?$2.10
Valuation & Ratios
Market Cap?11.0M
Shares Out?5.0M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short Interest?145.6K
Days to Cover?11.1
Avg Daily Volume13.1K
Settlement Date2026-09-30